Plaza Feed & Crop Nutrition announces Exclusive Agreement with Intralytix for Protein Live Production applications of proprietary bacteriophage kit.

BiomX ( ($PHGE) ) has issued an update. On December 8, 2025, BiomX Inc. announced the discontinuation of its Phase 2b clinical trial for BX004, a ...

University of Brighton researchers are leading a national project to develop a diagnostic tool to locate human sources of ...

A collaborative study, which includes contributions from NDORMS researchers Adam Crowther and supervisor Dario Carugo, ...

TARGETED and personalised therapies are expanding into a new area, focused not just on molecular receptors or immune signatures, but on ...

Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial ...

A new scientific review has uncovered how complex microbial communities, including those in the human gut and the natural ...

The European Commission and the World Health Organization have signed a 3.5 million EURO agreement under the EU4Health program to strengthen the global response to antimicrobial ...

The VinFuture 2025 Main Prize was awarded to four scientists from the United States for their discoveries and development of ...

Although the COVID pandemic led to a better understanding of the coronaviruses, viruses, and vaccines, a backlash emerged to ...